Total revenue for the full year 2025 reached $262.9 million, marking a 2% increase year-over-year, driven by new store openings. The Company reported a net loss of $68.6 million for the full year 2025, compared to a net loss of $48.8 million in 2024. Adjusted EBITDA for the full year 2025 was $50.3 million, an 8.8% increase from $46.2 million in 2024, with an Adjusted EBITDA margin of 19.1%. For the fourth quarter of 2025, total revenue was $68.3 million, up 3.8% year-over-year. Q4 2025 net loss was $15.6 million, compared to $12.5 million in Q4 2024. Q4 2025 Adjusted EBITDA significantly increased by 74% year-over-year to $13.9 million, achieving an Adjusted EBITDA margin of 20.4%. Subsequent to year-end, Jushi refinanced approximately $132.3 million of existing debt through a new $160.0 million 12.5% secured term loan due in 2029, enhancing liquidity and strengthening the balance sheet. Virginia adult-use cannabis legislation passed by the General Assembly, establishing a regulated retail market with sales projected to begin January 1, 2027, subject to the Governor's approval. The retail footprint expanded with eight new store openings since Q3 2024 through the end of 2025, bringing the total to 42 operating dispensaries. Jushi-branded products accounted for 58% of retail revenue across its five vertical markets in Q4 2025, an increase of 332 basis points year-over-year. Cash, cash equivalents, and restricted cash stood at $26.6 million as of December 31, 2025. Net cash flows provided by operations were $17.7 million for FY 2025 and $6.1 million for Q4 2025.